Annual Cash & Cash Equivalents
$123.25 M
-$38.05 M-23.59%
December 31, 2023
Summary
- As of February 7, 2025, SOPH annual cash & cash equivalents is $123.25 million, with the most recent change of -$38.05 million (-23.59%) on December 31, 2023.
- During the last 3 years, SOPH annual cash & cash equivalents has risen by +$48.63 million (+65.16%).
- SOPH annual cash & cash equivalents is now -36.13% below its all-time high of $192.96 million, reached on December 31, 2021.
Performance
SOPH Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$95.79 M
-$9.61 M-9.12%
September 30, 2024
Summary
- As of February 7, 2025, SOPH quarterly cash and cash equivalents is $95.79 million, with the most recent change of -$9.61 million (-9.12%) on September 30, 2024.
- Over the past year, SOPH quarterly cash and cash equivalents has dropped by -$36.98 million (-27.85%).
- SOPH quarterly cash and cash equivalents is now -54.38% below its all-time high of $209.99 million, reached on September 30, 2021.
Performance
SOPH Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SOPH Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -23.6% | -27.9% |
| 3 y3 years | +65.2% | -27.9% |
| 5 y5 years | +128.6% | -27.9% |
SOPH Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -36.1% | at low | -50.4% | at low |
| 5 y | 5-year | -36.1% | +582.1% | -54.4% | +125.5% |
| alltime | all time | -36.1% | +582.1% | -54.4% | +125.5% |
SOPHiA GENETICS SA Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $95.79 M(-9.1%) |
| Jun 2024 | - | $105.40 M(+1.6%) |
| Mar 2024 | - | $103.73 M(-15.8%) |
| Dec 2023 | $123.25 M(-23.6%) | $123.25 M(-7.2%) |
| Sep 2023 | - | $132.77 M(-10.6%) |
| Jun 2023 | - | $148.55 M(-7.6%) |
| Mar 2023 | - | $160.76 M(-0.3%) |
| Dec 2022 | $161.31 M | $161.31 M(+2.2%) |
| Sep 2022 | - | $157.83 M(-11.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $178.90 M(-2.2%) |
| Mar 2022 | - | $182.91 M(-5.2%) |
| Dec 2021 | $192.96 M(+158.6%) | $192.96 M(-8.1%) |
| Sep 2021 | - | $209.99 M(+394.2%) |
| Jun 2021 | - | $42.49 M(-25.6%) |
| Mar 2021 | - | $57.11 M(-23.5%) |
| Dec 2020 | $74.63 M(+313.0%) | - |
| Dec 2020 | - | $74.63 M |
| Dec 2019 | $18.07 M(-66.5%) | - |
| Dec 2018 | $53.91 M | - |
FAQ
- What is SOPHiA GENETICS SA annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for SOPHiA GENETICS SA?
- What is SOPHiA GENETICS SA annual cash & cash equivalents year-on-year change?
- What is SOPHiA GENETICS SA quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for SOPHiA GENETICS SA?
- What is SOPHiA GENETICS SA quarterly cash and cash equivalents year-on-year change?
What is SOPHiA GENETICS SA annual cash & cash equivalents?
The current annual cash & cash equivalents of SOPH is $123.25 M
What is the all time high annual cash & cash equivalents for SOPHiA GENETICS SA?
SOPHiA GENETICS SA all-time high annual cash & cash equivalents is $192.96 M
What is SOPHiA GENETICS SA annual cash & cash equivalents year-on-year change?
Over the past year, SOPH annual cash & cash equivalents has changed by -$38.05 M (-23.59%)
What is SOPHiA GENETICS SA quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SOPH is $95.79 M
What is the all time high quarterly cash and cash equivalents for SOPHiA GENETICS SA?
SOPHiA GENETICS SA all-time high quarterly cash and cash equivalents is $209.99 M
What is SOPHiA GENETICS SA quarterly cash and cash equivalents year-on-year change?
Over the past year, SOPH quarterly cash and cash equivalents has changed by -$36.98 M (-27.85%)